Say it louder for the folks in the back!! I get so mad when I do second opinions for premenopausal patients with node positive disease who were given only tamoxifen because their oncologists told them there “wasn’t a big difference” between tam and OA/AI. There is!!!!!
@BioMedCentral Cancer recently launched the Cancer Control in LMICs Collection. Please feel free to inquire or submit your manuscipts!
https://t.co/fMOtanmj8S
Privileged and honoured to present our work on Improving Access to Clinical Trials and Novel Therapeutics for Advanced Solid Tumours (ASTER Study) on behalf of @apoddc at #ESMOTATAsia25@danieltanmd@herbloong@DrBenTran Dr Tira Tan
Grateful for @myESMO Merit Travel Grant!
Let us please have our families, friends, and ourselves screened! Colonoscopy is recommended to start at 45 years old. 🙏
.
Link to full paper: https://t.co/omGh5qg7AS
.
#CancerCare#CancerIsNotADeathSentence#ThereIsAlwaysHope
Happy to be part of this study but at the same time a bit worried about the results.
.
Early Onset Colorectal Cancer incidence and mortality are expected to increase by approximately 20% from 2022 to 2050.
Low Human Development Index countries, Eastern Africa, Western Africa, and Middle Africa are projected to have more than double the number of cases and deaths (119.4% to 152.4% and 119.9% to 153.2%).
.
Great catching up with @JamesFanWu and @fredtingmd at #ASCO25! Always a pleasure to chat and share laughs while presenting our posters. Grateful for this brilliant community! 📸✨
Led by Marcky Antonio & @StephanieWang04 of @Harvard, mentored by @Erin_Feliciano, we present, "Financial toxicity of hemophilia care in Southeast Asian countries" in @LancetRH_SEAsia
🇧🇳🇲🇲🇰🇭🇮🇩🇱🇦🇲🇾🇵🇭🇸🇬🇹🇭🇹🇱🇻🇳
🙏 Drs @FredTingMD and Jeremiah Vallente
🔗 https://t.co/TZwDrRoBXJ
Some of the best parts of #ASCO25 is the opportunity to meet in person your research collaborators from around the world!!
Check one of our groups’ most recent publications on “National Cancer System Characteristics and Global Pan-Cancer Outcomes: https://t.co/1jbecD0JUb
Finally got my #HearHer pin from @NarjustFlorezMD!
For #lcsm, women have delays in diagnosis & treatment & younger women are diagnosed at greater rates than men!
Women are less likely to be offered #lcsm screening & enrolled in #lcsm clinical trials! #ASCO25
“No man is an island”
Dr @FredTingMD representing the Philippines 🇵🇭 and highlighting the importance for collaboration in clinical care, research, and policy for patients with #cancer